PET scan to monitor immunotherapy in pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working for pancreatic cancer. It may help your doctor understand if your treatment is effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pancreatic cancer
- Your doctor has recommended a combination of immunotherapy treatments
- You are between 18 and 75 years old
- Your overall health is good enough that you are expected to live more than 6 months
- You are willing to follow the study procedures and give your consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan called 68Ga-grazytracer to see how well immunotherapy is working in people with stomach, colon, or other gastrointestinal cancers. The goal is to find out if this scan can help doctors track your response to treatment.
This trial uses a special PET scan (68Ga-grazytracer) to see how well immunotherapy is working in people with advanced liver or bile duct cancer. The goal is to find a better way to monitor treatment response.
This trial tests a new imaging method called ImmunoPET to see if it can help detect pancreatic cancer more clearly. If you have or might have pancreatic cancer, this study could help doctors understand your condition better.
This study uses a special PET scan (a type of imaging) to look at tumors in people with pancreatic, lung, or bowel cancer. The scan uses a new tracer that may help doctors see cancer more clearly.
This trial tests a special PET scan (68Ga-grazytracer) to see if it can predict early whether immunotherapy is working in people with lung cancer that can be surgically removed. If successful, this scan could help doctors tailor treatment sooner.
This trial uses a special PET scan to see how well your breast cancer is responding to neoadjuvant therapy (treatment given before surgery). The goal is to help doctors personalize your care by checking if the cancer is shrinking.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.